|Bid||38.76 x 1800|
|Ask||40.00 x 800|
|Day's Range||38.04 - 39.71|
|52 Week Range||13.06 - 58.76|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||33.51|
|Earnings Date||Nov 5, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||45.50|
The Dow Jones Industrial Average and the Nasdaq composite have come significantly off intraday highs, but the advance is intact. Lululemon sold off.
The best mutual funds invested over $1 billion in Alibaba stock, and took large stakes in several other market leaders, including Microsoft, Splunk and CVS.
The Dow Jones Industrial Average and other indexes in the stock market are trying to limit the damage by President Trump's recent thoughts on trade talks.
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Software stocks succumbed to profit taking Monday, but the Dow Jones Industrial Average fell a bit less than the Nasdaq composite.
The Dow Jones Industrial Average continues to make solid gains in the fourth quarter, but now the Russell 2000 is outperforming for the year.
Discover 12 stocks, including Kirkland Lake Gold, InMode, Incyte, and Inphi expecting earnings growth above 50% this year.
The Dow Jones Industrial Average has lagged in a bullish fourth quarter as this index ETF races 2% higher. Growth stocks show solid post-breakout gains.
Futures: The stock market just edged lower Thursday despite hefty losses in some chip stocks and other leaders. The Tesla cybertruck unveiling is on tap.
The market continued to trim losses Thursday afternoon, but weakness in semiconductor stocks kept the Nasdaq composite lower, while two crumbling stocks hurt the IBD 50.
In the daily Japanese candlestick chart of INMD, below, we can see that prices have climbed rapidly in a parabolic manner this month. In this Point and Figure chart of INMD, below, we can see the big uptrend and a price target of $65. Bottom-line strategy: Our Point and Figure chart still shows a potential price target of $65 but we see a number of clues that indicate we could be an important juncture.
The Nasdaq composite, fueled by semiconductor and software stocks lately, bulldozed into new high ground. Some leaders are up 25% or more from buy points.
During the Lightning Round segment of Mad Money Tuesday evening one caller asked about the new issue InMode Ltd. : "This one is speculative and it's had a big run," commented Jim Cramer. The company is a global provider of innovative medical technologies. The trading volume has increased from the start of trading and the daily On-Balance-Volume (OBV) line shows a rise in the past few months telling us that buyers of INMD have been more aggressive.
YOQNEAM, Israel , Nov. 12, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy , Chairman ...
LOS ANGELES , Nov. 7, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to support the initiatives of Operation ...
YOKNEAM, Israel , Nov. 5, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for the third ...
Carvana, DocuSign, InMode and Azul are recent IPO stocks near buy zones, All but DocuSign report this week. Newborn IPO Progyny is also worth watching.
LAKE FOREST, Calif. , Oct. 31, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is proud to announce that it has received ...
Among IBD 50 stocks to watch, InMode has shown some beautiful short-term price runs. But it can also fall quickly too. What is the stock chart showing now?
This week my pick is InMode Ltd. . InMode is an Israeli company that develops, manufactures and sells devices that use its unique, minimally invasive radio-frequency (RF) technology for cosmetic surgery, dermatology, gynecology and various other medical specialties. InMode shares were offered at $14 in an IPO on August 8 and the company released second-quarter results a few days later.
InMode is the IBD Stock Of The Day as the medical aesthetics company approaches another expected quarter of growing profitability. InMode makes body/skin tightening devices.
The stock market turned slightly lower in afternoon trading Monday as Wall Street weighed the latest developments in the China trade war.